-
Galderma Laboratories L.P. et al v. Amneal Pharmaceuticals LLC et al DC CAFC
- 1:16-cv-00207
- D. Del.
- Judge: Leonard P. Stark
- Filed: 03/31/2016
- Closed: 09/04/2018
- Latest Docket Entry: 06/09/2020
- PACER
- Docket updated daily
3
Plaintiffs
2
Defendants
1
Accused
Product
10
Patents-in-Suit
888
Days in
Litigation
-
Galderma Laboratories L.P. et al v. Amneal Pharmaceuticals LLC et al DC CAFC
- 1:16-cv-00207
- D. Del.
- Judge: Leonard P. Stark
- Filed: 03/31/2016
- Closed: 09/04/2018
- Latest Docket Entry: 06/09/2020
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 30 |
A method according to claim 26, wherein the sub-antibacterial amount is an amount that results in no reduction of skin microflora during a six-month treatment.
|
Valid
Entry 296 |
| Claim # | Claim Text | Outcome |
|---|---|---|
| 14 |
A method according to claim 12, wherein said doxycycline or pharmaceutically acceptable salt thereof is administered in an amount of 40 milligrams.
|
Valid
Entry 296 |
| 15 |
A method according to claim 14, wherein said doxycycline or pharmaceutically acceptable salt thereof is administered by sustained release.
|
Valid
Entry 296 |
| 23 |
A method according to claim 20, wherein said hydrate of doxycycline is administered in an amount of 40 milligrams.
|
Valid
Entry 296 |
| 24 |
A method according to claim 20, wherein said hydrate of doxycycline is administered by sustained release.
|
Valid
Entry 296 |
| 26 |
A method according to claim 23, wherein said hydrate of doxycycline is administered once a day.
|
Valid
Entry 296 |
| Claim # | Claim Text | Outcome |
|---|---|---|
| 3 |
The method according to claim 2, wherein said doxycycline monohydrate is administered in an amount of 40 milligrams.
|
Valid
Entry 296 |
| 4 |
The method according to claim 3, wherein said doxycycline monohydrate is administered by sustained release.
|
Valid
Entry 296 |
| 5 |
A method according to claim 4, wherein said doxycycline monohydrate is administered once a day.
|
Valid
Entry 296 |
| 15 |
A method for treating papules and pustules of rosacea in a human in need thereof, the method comprising administering orally to said human doxycycline, or a pharmaceutically acceptable salt thereof, in an amount of 40 mg per day, wherein the amount
view more
|
Valid
Entry 296 |
| 16 |
The method according to claim 15, wherein said doxycycline is doxycycline monohydrate.
|
Valid
Entry 296 |
| Claim # | Claim Text | Outcome |
|---|---|---|
| 13 |
A method for treating acne in a human in need thereof, the method comprising administering orally to said human doxycycline, or a pharmaceutically acceptable salt thereof, in an amount of 40 mg per day, wherein the amount results in no reduction of
view more
|
Valid
Entry 296 |
| 14 |
The method according to claim 13, wherein said doxycycline is doxycycline monohydrate.
|
Valid
Entry 296 |
| 15 |
The method according to claim 14, wherein said doxycycline monohydrate is administered by sustained release.
|
Valid
Entry 296 |
| 16 |
A method according to claim 15, wherein said doxycycline monohydrate is administered once a day.
|
Valid
Entry 296 |
-
Infringement
Amneal Pharmaceuticals Co (I) Pvt Ltd
- 8 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 40 mg doxycycline oral capsule | US 7,211,267 B2 |
30
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 7,232,572 B2 |
14, 15, 23, 24, 26
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 7,749,532 B2 |
1
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 8,206,740 B2 |
1
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 8,394,405 B2 |
1, 3
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 8,470,364 B2 |
1, 2
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 8,603,506 B2 |
3, 4, 5, 15, 16
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 9,241,946 B2 |
13, 14, 15, 16
|
Infringement
Entry 296
|
Amneal Pharmaceuticals, LLC
- 8 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 40 mg doxycycline oral capsule | US 7,211,267 B2 |
30
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 7,232,572 B2 |
14, 15, 23, 24, 26
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 7,749,532 B2 |
1
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 8,206,740 B2 |
1
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 8,394,405 B2 |
1, 3
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 8,470,364 B2 |
1, 2
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 8,603,506 B2 |
3, 4, 5, 15, 16
|
Infringement
Entry 296
|
| 40 mg doxycycline oral capsule | US 9,241,946 B2 |
13, 14, 15, 16
|
Infringement
Entry 296
|
